TCF25 as a Nutrient Sensor in Lysosomal Metabolic Adaptation and Cell Fate

Study Background and Research Question

Cellular adaptation to nutrient stress is fundamental for survival, especially under conditions of glucose deprivation. Glucose, the primary energy substrate for most eukaryotic cells, supports ATP production and biosynthetic processes. When glucose becomes limited, cells activate a range of compensatory pathways, including AMPK activation and autophagy, to maintain energy balance and viability. However, under persistent glucose starvation, these adaptive processes may ultimately lead to cell death. Despite advances in understanding metabolic reprogramming, the precise regulatory mechanisms that link nutrient sensing, lysosomal adaptation, and the decision between survival and death during glucose deprivation remain incompletely defined. Ren et al. (2025) address this gap by investigating the role of transcription factor TCF25 in orchestrating lysosomal responses to glucose starvation and their consequences for cell fate (Ren et al., 2025).

Key Innovation from the Reference Study

The principal innovation of this study is the identification of TCF25 as a nutrient sensor that modulates lysosomal acidification and autophagy, thereby determining cell fate under glucose starvation. Using a genome-wide CRISPR-Cas9 screen, the authors discovered that TCF25 plays a non-redundant role in enhancing lysosomal acidification via upregulation of V-ATPase, a proton pump complex critical for lysosomal function. Under prolonged glucose deprivation, TCF25-driven lysosomal activity promotes ferritinophagy—selective autophagic degradation of ferritin—leading to increased lysosomal iron and triggering lysosome-dependent cell death (LDCD). This regulatory axis highlights a direct molecular link between nutrient sensing, iron metabolism, and cell death pathways.

Methods and Experimental Design Insights

Ren et al. employed a multi-tiered approach combining functional genomics, molecular biology, and in vivo modeling. The workflow began with a genome-wide CRISPR-Cas9 knockout screen in mammalian cells exposed to glucose-starved conditions, aiming to identify genes essential for starvation-induced cell death. TCF25 emerged as a top candidate from an enriched lysosomal pathway gene set. Subsequent experiments included genetic ablation (knockout/knockdown) of TCF25 and V-ATPase subunits, live-cell imaging of lysosomal pH, immunoblotting for autophagy markers, and quantification of ferritinophagy. To assess physiological relevance, hepatic ischemia-reperfusion injury (IRI) models were used in mice with TCF25 deficiency to evaluate tissue protection under metabolic stress. This integrative design enabled the elucidation of TCF25’s role at molecular, cellular, and organismal levels.

Core Findings and Why They Matter

• TCF25 is Required for Glucose Starvation-Induced Cell Death: Loss-of-function screening revealed that TCF25 deficiency protected cells from death during glucose deprivation. This effect was linked to impaired lysosomal acidification and autophagic flux.
• Enhancement of Lysosomal Acidification via V-ATPase: Mechanistically, TCF25 upregulated V-ATPase activity, increasing lysosomal proton influx, which is essential for degradation of autophagic cargo and energy recycling during nutrient scarcity (Ren et al., 2025).
• TCF25-Driven Ferritinophagy Promotes Lysosome-Dependent Cell Death: While initial autophagic responses protect cell viability, prolonged TCF25-mediated activation promotes ferritinophagy, resulting in iron release within lysosomes. Accumulation of iron increases lysosomal membrane permeability (LMP), leading to LDCD. Both TCF25 and V-ATPase knockout cells were resistant to this iron-dependent cell death.
• Protection Against Ischemia-Reperfusion Injury in Vivo: TCF25 knockout mice displayed reduced liver injury following hepatic IRI, supporting the translational significance of targeting this pathway in metabolic and ischemic disorders.

These findings provide a mechanistic framework linking nutrient sensing, lysosomal adaptation, and regulated cell death, with TCF25 as a central hub. The intersection of autophagy and iron metabolism via ferritinophagy may represent a vulnerability in metabolic stress and ischemic tissue injury.

Comparison with Existing Internal Articles

The connection between lysosomal iron handling and cell viability is of particular interest in the context of iron overload treatment research and beta-thalassemia iron chelation. Internal articles such as "Deferasirox Fe3+ chelate: Oral Iron Chelator for Iron Overload Treatment" and "Deferasirox Fe3+ chelate: Streamlining Iron Overload Research" describe the application of Deferasirox Fe3+ chelate—a tridentate, DMSO-soluble iron chelator—in modeling ferric iron (Fe3+) dynamics and preventing iron-induced toxicity. While these articles focus on iron chelation mechanisms in chronic anemia and beta-thalassemia models, the mechanistic insights from Ren et al. highlight the importance of lysosomal iron release (via ferritinophagy) as a critical step in cell death during metabolic stress. Thus, the new evidence expands the scope for experimental designs that combine iron chelation tools with autophagy and cell death assays to dissect lysosomal iron’s dual role in adaptation and toxicity.

Limitations and Transferability

Despite its comprehensive design, the study has several limitations. First, while the CRISPR-Cas9 screen and mechanistic follow-up were robust in vitro, the in vivo validation was limited to hepatic ischemia-reperfusion injury, leaving open questions about relevance in other tissues or disease models. The role of TCF25 in human pathophysiology, especially in chronic iron overload conditions such as beta-thalassemia or chronic anemia, remains to be established. The interplay between TCF25-driven ferritinophagy and other forms of regulated cell death (e.g., ferroptosis, necroptosis) also warrants further investigation. Transferability to clinical contexts will require careful consideration of species differences and compensatory pathways in more complex systems.

Protocol Parameters

• TCF25 knockout/knockdown: Use CRISPR-Cas9 or shRNA targeting validated exons; confirm by sequencing and immunoblotting.
• Glucose starvation induction: Replace culture medium with glucose-free DMEM; monitor for 6–48 hours depending on experimental endpoint.
• Lysosomal acidification assessment: Employ pH-sensitive dyes (e.g., LysoSensor) and calibrate with nigericin buffers for quantitative comparison.
• Ferritinophagy analysis: Monitor NCOA4 and ferritin degradation by immunoblot; assess lysosomal iron with fluorescent probes or chelation controls.
• Cell viability measurement: Use propidium iodide exclusion, LDH release, or caspase activation assays post-starvation.
• In vivo IRI modeling: Induce partial hepatic ischemia in mice (e.g., 60 minutes), followed by reperfusion; analyze serum transaminases and histopathology.

Research Support Resources

For researchers aiming to explore iron chelation mechanisms or model lysosomal iron dynamics in the context of autophagy and cell death, Deferasirox Fe3+ chelate (SKU A3355) provides a high-purity, DMSO-soluble tool compound validated for iron overload and beta-thalassemia iron chelation studies. As described in recent workflow articles, Deferasirox Fe3+ chelate can be integrated into protocols assessing ferritinophagy, lysosomal acidification, and iron-dependent cell death, supporting mechanistic investigations derived from the latest lysosomal adaptation research. APExBIO supplies this reagent for research use only; consult the product information and relevant literature for guidance on experimental design and compound handling.